Top Authors

• Most frequent coverage on ARNA

• 
  SA Editor Miriam Metzinger (541 followers)

  • Jim Cramer's Mad Money Lightning Round Picks, Feb. 15 (Fri, Feb 16)
  • Jim Cramer's Mad Money In-Depth Stock Picks, Nov. 29 (Thu, Nov 30)
  • Jim Cramer's Mad Money Lightning Round Picks, Nov. 16 (Fri, Nov 17)

  More by SA Editor Miriam Metzinger on ARNA »
• 
  Ruthanne Roussel (75 followers)

  • Don't Expect Amylin to Eat the Obesity Market's Lunch (Mon, Nov 2)
  • Why Orexigen's Empatic News Is Good (Fri, Oct 2)
  • Two Positive Notes for Arena Pharmaceuticals (Fri, Sep 18)

  More by Ruthanne Roussel on ARNA »
• 
  Mike Havrilla (1939 followers)

  • BioMed News Bytes: Arena, Momenta, Vivus (Sun, Sep 20)
  • BioMed News Bytes: Arena, ImmunoCellular, YM Bio (Fri, Sep 18)
  • Five Small-Cap Weight Loss Trades (Wed, Jul 22)

  More by Mike Havrilla on ARNA »

• Most followed authors on ARNA

• 
  Philip Davis (5899 followers)

  • Options Trader: Wednesday Outlook, Fed Edition (Wed, Nov 4)
  • Options Trader Testy Tuesday Outlook: Dow 9,650, Berkshire $60 Edition (Tue, Nov 3)

  More by Philip Davis on ARNA »
• 
  Bespoke Investment Group (3546 followers)

  • Companies With The Most Analyst Attention & Affection (Tue, Jun 5)

  More by Bespoke Investment Group on ARNA »
• 
  SA Editor Rachael Granby (2022 followers)

  • Wall Street Breakfast: Must-Know News (Tue, Aug 4)

  More by SA Editor Rachael Granby on ARNA »

• Newest authors on ARNA

• 
  Penn Bioinvestor (59 followers)

  • Vivus: Obesity Experimental Drug Has Promising Outlook (Wed, Jul 8)

  More by Penn Bioinvestor on ARNA »
• 
  Beacon Asset Managers (131 followers)

  • Arena's Edge in the Obesity Drug Race (Sun, Jul 26)

  More by Beacon Asset Managers on ARNA »
• 
  M. E. Garza (522 followers)

  • 6 Healthcare Stocks to Watch (Tue, Jun 16)
  • Bio Medical Stock Sector is Where the Action Is (Tue, Jun 9)

  More by M. E. Garza on ARNA »

• Most commented on ARNA

• 
  Ruthanne Roussel (75 followers)

  • Don't Expect Amylin to Eat the Obesity Market's Lunch (Mon, Nov 2)
  • Why Orexigen's Empatic News Is Good (Fri, Oct 2)
  • Two Positive Notes for Arena Pharmaceuticals (Fri, Sep 18)

  More by Ruthanne Roussel on ARNA »
• 
  Michael Murphy (528 followers)

  • Investing in the Obesity Drug Basket (Mon, Sep 21)
  • A Biotech Triple Play: Dendreon, BioCryst and Arena (Mon, May 25)

  More by Michael Murphy on ARNA »
• 
  Derek Lowe (132 followers)

  • Arena's Prospects Will Be in the Eye of the Suitors (Sun, May 24)
  • Arena Pharma Could Be on the Verge of Collapse (Mon, May 18)
  • Arena's Obesity Drug Not Likely to Make It (Tue, Mar 31)

  More by Derek Lowe on ARNA »